发明名称 New variants of tridegin, useful as anticoagulant and thrombolytic agents, inhibit factor 13a and have e.g. improved stability against aggregation
摘要 Variants of the tridegin polypeptide having the 68 amino acid sequence defined in the specification, are new. Variants of the tridegin polypeptide having the 68 amino acid sequence defined in the specification, are new. The variants (I) have one of the following modifications: (a) substitution of at least one Cys by some other amino acid; (b) substitution of Lys2 or 7, His10, Gly12, Leu24, Tyr31, Phe34 or 58, Arg39, Ile45, Met48, Asp50, Pro55 or 65, or Asn60 by some other amino acid; (c) deletion at either end provided the remaining peptide includes at least the sequence Asp-Asp-Ile-Tyr-Gln-Arg-X-Val-X-Phe-Pro-X-Leu-Pro-Leu, where X is any amino acid; and/or (d) covalent attachment of poly(ethylene glycol). Independent claims are also included for the following: (1) compounds (II) that contain at least one (I); and (2) method for preparing (I) and (II) by genetic engineering or peptide-chemical methods.
申请公布号 DE10163333(A1) 申请公布日期 2003.07.10
申请号 DE20011063333 申请日期 2001.12.21
申请人 CURACYTE AG 发明人 GIERSIEFEN, HELMUT;STOECKEL, JOHANNES;PAMP, TANJA;OHLMANN, MARION
分类号 A61K38/00;C07K14/435;(IPC1-7):C07K7/08;A61K38/10;A61K38/16;C07K14/245 主分类号 A61K38/00
代理机构 代理人
主权项
地址